GlassScriptPhysician profile
William M Leuchter
NPI 1619970423
$2,637.03
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,491 · 2020: $17.86 · 2021: $75.27 · 2023: $52.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $508.41 | 2019-2021 | |
| Emd Serono, INC. | $441.71 | 2019 | |
| Mdd US Operations, LLC | $198.41 | 2019 | |
| Alexion Pharmaceuticals, INC. | $183.42 | 2019 | |
| Avanir Pharmaceuticals, INC. | $121.97 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $114.91 | 2019 | |
| Abbvie INC. | $108.20 | 2019-2023 | |
| Genentech USA, INC. | $107.34 | 2019 | |
| Genzyme Corporation | $92.17 | 2019 | |
| Ucb, INC. | $89.94 | 2019 | |
| Scilex Pharmaceuticals INC. | $89.55 | 2019 | |
| Sunovion Pharmaceuticals INC. | $79.04 | 2019 | |
| Allergan, INC. | $65.57 | 2019 | |
| Validus Pharmaceuticals LLC | $56.33 | 2019 | |
| Bausch Health US, LLC | $53.92 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $48.27 | 2019 | |
| Biogen, INC. | $39.45 | 2019 | |
| Ge Healthcare | $35.16 | 2019 | |
| Amgen INC. | $33.12 | 2019 | |
| Lilly USA, LLC | $27.23 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.03 | 2019 | |
| Genentech, INC. | $22.01 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.02 | 2019 | |
| Upsher-Smith Laboratories LLC | $17.86 | 2020 | |
| Lundbeck LLC | $16.83 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $14.64 | 2019 | |
| Promius Pharma LLC | $12.58 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Leuchter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.